Table 1.
Characteristic | All | Substudy |
---|---|---|
Number of subjects | 119 | 52 |
Race | ||
Black | 71 (60%) | 32 (62%) |
Ethnicity | ||
Latino | 41 (34%) | 21 (40%) |
Age (years) | ||
Median | 29 | 27 |
Interquartile range (IQR) | (22, 32) | (23, 31) |
Gestational age (weeks) | ||
Median | 25 | 27 |
IQR | (20, 29) | (21, 30) |
Receiving ARVs | 119 (100%) | 52 (100%) |
Type of ARV regimen | ||
HAART | 112 (94%) | 46 (88%) |
Other | 7 (6%) | 6 (12%) |
CD4 percent | ||
Median | 32 | 33 |
IQR | (23, 39) | (27, 41) |
CD4 count (cells/mm3) | ||
Median | 481 | 496 |
IQR | (350, 647) | (388, 635) |
CD8 percent | ||
Median | 46 | 44 |
IQR | (38, 52) | (38, 51) |
CD8 count (cells/mm3) | ||
Median | 686 | 643 |
IQR | (529, 893) | (527, 851) |
N | N = 109 | N = 49 |
log10 RNA count | ||
Mediana | 1.9 | 1.9 |
IQR | (1.7, 2.6) | (1.7, 2.6) |
The lower limit of detection varied among subjects depending on the assay used at the clinical research site; RNA values below the limit of detection were replaced with the lower detection limit of the assay.